JNJ
Price
$154.09
Change
-$0.84 (-0.54%)
Updated
Apr 25, 04:48 PM (EDT)
Capitalization
380.22B
88 days until earnings call
RHHBY
Price
$39.75
Change
+$0.61 (+1.56%)
Updated
Apr 24 closing price
Capitalization
250.69B
90 days until earnings call
Ad is loading...

JNJ vs RHHBY

Header iconJNJ vs RHHBY Comparison
Open Charts JNJ vs RHHBYBanner chart's image
Johnson & Johnson
Price$154.09
Change-$0.84 (-0.54%)
Volume$23.64K
Capitalization380.22B
Roche Holding
Price$39.75
Change+$0.61 (+1.56%)
Volume$3.34M
Capitalization250.69B
JNJ vs RHHBY Comparison Chart
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JNJ vs. RHHBY commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a Buy and RHHBY is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (JNJ: $154.93 vs. RHHBY: $39.75)
Brand notoriety: JNJ: Notable vs. RHHBY: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 80% vs. RHHBY: 87%
Market capitalization -- JNJ: $380.22B vs. RHHBY: $250.69B
JNJ [@Pharmaceuticals: Major] is valued at $380.22B. RHHBY’s [@Pharmaceuticals: Major] market capitalization is $250.69B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 2 FA rating(s) are green whileRHHBY’s FA Score has 2 green FA rating(s).

  • JNJ’s FA Score: 2 green, 3 red.
  • RHHBY’s FA Score: 2 green, 3 red.
According to our system of comparison, JNJ is a better buy in the long-term than RHHBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 5 TA indicator(s) are bullish while RHHBY’s TA Score has 5 bullish TA indicator(s).

  • JNJ’s TA Score: 5 bullish, 5 bearish.
  • RHHBY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, RHHBY is a better buy in the short-term than JNJ.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а -1.61% price change this week, while RHHBY (@Pharmaceuticals: Major) price change was +2.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.09%. For the same industry, the average monthly price growth was -2.58%, and the average quarterly price growth was -8.77%.

Reported Earning Dates

JNJ is expected to report earnings on Jul 22, 2025.

RHHBY is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.09% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than RHHBY($251B). JNJ has higher P/E ratio than RHHBY: JNJ (30.34) vs RHHBY (19.46). RHHBY YTD gains are higher at: 17.752 vs. JNJ (7.987). JNJ has higher annual earnings (EBITDA): 23.3B vs. RHHBY (19.1B). JNJ has more cash in the bank: 22.9B vs. RHHBY (7.51B). RHHBY has less debt than JNJ: RHHBY (25.4B) vs JNJ (29.3B). JNJ has higher revenues than RHHBY: JNJ (85.2B) vs RHHBY (60B).
JNJRHHBYJNJ / RHHBY
Capitalization380B251B151%
EBITDA23.3B19.1B122%
Gain YTD7.98717.75245%
P/E Ratio30.3419.46156%
Revenue85.2B60B142%
Total Cash22.9B7.51B305%
Total Debt29.3B25.4B115%
FUNDAMENTALS RATINGS
JNJ vs RHHBY: Fundamental Ratings
JNJ
RHHBY
OUTLOOK RATING
1..100
6526
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
15
Undervalued
PROFIT vs RISK RATING
1..100
3073
SMR RATING
1..100
45100
PRICE GROWTH RATING
1..100
5148
P/E GROWTH RATING
1..100
6412
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBY's Valuation (15) in the null industry is in the same range as JNJ (17) in the Pharmaceuticals Major industry. This means that RHHBY’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (30) in the Pharmaceuticals Major industry is somewhat better than the same rating for RHHBY (73) in the null industry. This means that JNJ’s stock grew somewhat faster than RHHBY’s over the last 12 months.

JNJ's SMR Rating (45) in the Pharmaceuticals Major industry is somewhat better than the same rating for RHHBY (100) in the null industry. This means that JNJ’s stock grew somewhat faster than RHHBY’s over the last 12 months.

RHHBY's Price Growth Rating (48) in the null industry is in the same range as JNJ (51) in the Pharmaceuticals Major industry. This means that RHHBY’s stock grew similarly to JNJ’s over the last 12 months.

RHHBY's P/E Growth Rating (12) in the null industry is somewhat better than the same rating for JNJ (64) in the Pharmaceuticals Major industry. This means that RHHBY’s stock grew somewhat faster than JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJRHHBY
RSI
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
45%
Momentum
ODDS (%)
Bullish Trend 2 days ago
39%
Bullish Trend 2 days ago
45%
MACD
ODDS (%)
Bullish Trend 2 days ago
37%
Bullish Trend 2 days ago
47%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
42%
Bullish Trend 2 days ago
49%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
49%
Advances
ODDS (%)
Bullish Trend 9 days ago
40%
Bullish Trend 2 days ago
50%
Declines
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 18 days ago
44%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
51%
Aroon
ODDS (%)
Bearish Trend 2 days ago
31%
Bearish Trend 2 days ago
42%
View a ticker or compare two or three
Ad is loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCAL13.480.42
+3.22%
California BanCorp
CASI2.020.02
+0.75%
CASI Pharmaceuticals
ALEX16.710.07
+0.42%
Alexander & Baldwin
UBSI34.46-0.01
-0.03%
United Bankshares
CNC61.58-0.54
-0.87%
Centene Corp

RHHBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBY has been loosely correlated with RHHVF. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBY jumps, then RHHVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBY
1D Price
Change %
RHHBY100%
+1.56%
RHHVF - RHHBY
65%
Loosely correlated
+1.78%
NVS - RHHBY
37%
Loosely correlated
+0.94%
JNJ - RHHBY
37%
Loosely correlated
-0.29%
RHHBF - RHHBY
32%
Poorly correlated
+6.89%
BMY - RHHBY
28%
Poorly correlated
+0.33%
More